The Porphyrias

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationGoldman's Cecil Medicine: Twenty Fourth Edition
PublisherElsevier Inc.
Pages1363-1371
Number of pages9
Volume2
ISBN (Print)9781437716047
DOIs
StatePublished - Jul 2011

ASJC Scopus subject areas

  • Social Sciences(all)

Cite this

Anderson, K. (2011). The Porphyrias. In Goldman's Cecil Medicine: Twenty Fourth Edition (Vol. 2, pp. 1363-1371). Elsevier Inc.. https://doi.org/10.1016/B978-1-4377-1604-7.00217-7

The Porphyrias. / Anderson, Karl.

Goldman's Cecil Medicine: Twenty Fourth Edition. Vol. 2 Elsevier Inc., 2011. p. 1363-1371.

Research output: Chapter in Book/Report/Conference proceedingChapter

Anderson, K 2011, The Porphyrias. in Goldman's Cecil Medicine: Twenty Fourth Edition. vol. 2, Elsevier Inc., pp. 1363-1371. https://doi.org/10.1016/B978-1-4377-1604-7.00217-7
Anderson K. The Porphyrias. In Goldman's Cecil Medicine: Twenty Fourth Edition. Vol. 2. Elsevier Inc. 2011. p. 1363-1371 https://doi.org/10.1016/B978-1-4377-1604-7.00217-7
Anderson, Karl. / The Porphyrias. Goldman's Cecil Medicine: Twenty Fourth Edition. Vol. 2 Elsevier Inc., 2011. pp. 1363-1371
@inbook{2075e9ae740f4361b9d6e17865df8596,
title = "The Porphyrias",
author = "Karl Anderson",
year = "2011",
month = "7",
doi = "10.1016/B978-1-4377-1604-7.00217-7",
language = "English (US)",
isbn = "9781437716047",
volume = "2",
pages = "1363--1371",
booktitle = "Goldman's Cecil Medicine: Twenty Fourth Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - The Porphyrias

AU - Anderson, Karl

PY - 2011/7

Y1 - 2011/7

UR - http://www.scopus.com/inward/record.url?scp=84904370306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904370306&partnerID=8YFLogxK

U2 - 10.1016/B978-1-4377-1604-7.00217-7

DO - 10.1016/B978-1-4377-1604-7.00217-7

M3 - Chapter

AN - SCOPUS:84904370306

SN - 9781437716047

VL - 2

SP - 1363

EP - 1371

BT - Goldman's Cecil Medicine: Twenty Fourth Edition

PB - Elsevier Inc.

ER -